Two Sigma Advisers’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.45M Buy
290,400
+22,300
+8% +$495K 0.01% 653
2025
Q1
$4.98M Sell
268,100
-25,200
-9% -$468K 0.01% 794
2024
Q4
$3.88M Buy
293,300
+107,800
+58% +$1.43M 0.01% 821
2024
Q3
$6.21M Buy
185,500
+63,100
+52% +$2.11M 0.01% 642
2024
Q2
$3.07M Sell
122,400
-9,300
-7% -$233K 0.01% 974
2024
Q1
$2.97M Buy
131,700
+32,500
+33% +$732K 0.01% 1020
2023
Q4
$2.12M Sell
99,200
-17,900
-15% -$383K 0.01% 1254
2023
Q3
$2.1M Sell
117,100
-8,900
-7% -$160K 0.01% 1175
2023
Q2
$2.56M Buy
126,000
+57,100
+83% +$1.16M 0.01% 1064
2023
Q1
$1.5M Sell
68,900
-17,900
-21% -$390K ﹤0.01% 1428
2022
Q4
$2.69M Buy
86,800
+30,500
+54% +$945K 0.01% 1077
2022
Q3
$1.44M Sell
56,300
-5,000
-8% -$128K ﹤0.01% 1344
2022
Q2
$1.24M Sell
61,300
-16,100
-21% -$327K ﹤0.01% 1469
2022
Q1
$1.92M Sell
77,400
-48,100
-38% -$1.19M 0.01% 1281
2021
Q4
$4.36M Sell
125,500
-44,400
-26% -$1.54M 0.01% 826
2021
Q3
$4.61M Sell
169,900
-99,100
-37% -$2.69M 0.01% 824
2021
Q2
$6.98M Sell
269,000
-145,700
-35% -$3.78M 0.02% 706
2021
Q1
$8.94M Buy
414,700
+29,800
+8% +$642K 0.02% 624
2020
Q4
$8.28M Buy
384,900
+107,000
+39% +$2.3M 0.02% 639
2020
Q3
$4.1M Sell
277,900
-130,600
-32% -$1.93M 0.01% 836
2020
Q2
$9.13M Buy
408,500
+8,500
+2% +$190K 0.03% 587
2020
Q1
$5.65M Buy
400,000
+138,100
+53% +$1.95M 0.02% 668
2019
Q4
$4.26M Buy
261,900
+210,700
+412% +$3.42M 0.01% 906
2019
Q3
$1.79M Buy
51,200
+5,400
+12% +$189K ﹤0.01% 1158
2019
Q2
$2.58M Buy
45,800
+6,100
+15% +$344K 0.01% 1101
2019
Q1
$2.9M Sell
39,700
-9,700
-20% -$709K 0.01% 1063
2018
Q4
$3.15M Sell
49,400
-11,700
-19% -$746K 0.01% 981
2018
Q3
$6.1M Buy
61,100
+14,000
+30% +$1.4M 0.01% 755
2018
Q2
$3.35M Buy
47,100
+43,700
+1,285% +$3.1M 0.01% 1051
2018
Q1
$354K Buy
+3,400
New +$354K ﹤0.01% 1953